The global synthetic human growth hormone market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of chronic renal insufficiency and Turner syndrome, which are driving the demand for synthetic human growth hormone. The global synthetic human growth hormone market is segmented on the basis of type into powder and solvent; on the basis of application into GHD, Turner syndrome, chronic renal insufficiency, Prader Willi Syndrome (PWS), small for gestational age (SGA), SHOX deficiency; and by region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa. The North American region dominates this market with a share of over 40%. This can be attributed to high prevalence rates in chronic renal insufficiency in this region as well as increased awareness about GHD among patients suffering from it.
Some Of The Growth Factors Of This Market:
- Synthetic human growth hormone is used for treating children with short stature or idiopathic short stature as well as adults who are suffering from conditions such as Turner syndrome or Prader-Willi syndrome which cause them to have low levels of natural HGH production in their bodies. It can also be used for treating patients who have been diagnosed with HIV/AIDS or cancer that has spread throughout the body and causes cachexia (wasting away).
- Synthetic human growth hormone injections are administered once every two weeks while oral tablets are taken daily for three months followed by one month off treatment cycle before starting another course of treatment cycle again if required . This makes it more convenient than other treatments which require daily injections over an extended period of time which may not be feasible for some patients due to side effects such as pain at injection site, muscle aches, joint pain etc, especially when they need long-term treatment cycles like those prescribed for HIV/AIDS patients who need lifelong therapy because they cannot stop taking it without risking their health deteriorating rapidly.
Industry Growth Insights published a new data on “Synthetic Human Growth Hormone Market”. The research report is titled “Synthetic Human Growth Hormone Market research by Types (Powder, Solvent), By Applications (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others), By Players/Companies Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology, BioPartners”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Synthetic Human Growth Hormone Market Research Report
By Type
Powder, Solvent
By Application
Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others
By Companies
Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology, BioPartners
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Synthetic Human Growth Hormone Market Report Segments:
The global Synthetic Human Growth Hormone market is segmented on the basis of:
Types
Powder, Solvent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Pfizer
- Eli Lilly
- Merck Serono
- F.Hoffmann-La Roche
- Ferring Pharmaceuticals
- GeneScience Pharmaceuticals
- Ipsen
- LG Life Sciences
- Sandoz International
- Anhui Anke Biotechnology
- BioPartners
Highlights of The Synthetic Human Growth Hormone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Solvent
- By Application:
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Synthetic Human Growth Hormone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Synthetic human growth hormone is a man-made version of the natural hormone produced by the pituitary gland. It is used to treat short stature in children and adults, as well as other conditions that are caused by a lack of growth hormone.
Some of the major players in the synthetic human growth hormone market are Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology, BioPartners.
The synthetic human growth hormone market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Synthetic Human Growth Hormone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Synthetic Human Growth Hormone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Synthetic Human Growth Hormone Market - Supply Chain
4.5. Global Synthetic Human Growth Hormone Market Forecast
4.5.1. Synthetic Human Growth Hormone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Synthetic Human Growth Hormone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Synthetic Human Growth Hormone Market Absolute $ Opportunity
5. Global Synthetic Human Growth Hormone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Solvent
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Synthetic Human Growth Hormone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
6.3.1. Growth Hormone Deficiency (GHD)
6.3.2. Turner Syndrome
6.3.3. Chronic Renal Insufficiency
6.3.4. Prader Willi Syndrome
6.3.5. Small for Gestational Age
6.3.6. SHOX Deficiency
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Synthetic Human Growth Hormone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Synthetic Human Growth Hormone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Synthetic Human Growth Hormone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Synthetic Human Growth Hormone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Synthetic Human Growth Hormone Demand Share Forecast, 2019-2026
9. North America Synthetic Human Growth Hormone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Synthetic Human Growth Hormone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
9.4.1. Growth Hormone Deficiency (GHD)
9.4.2. Turner Syndrome
9.4.3. Chronic Renal Insufficiency
9.4.4. Prader Willi Syndrome
9.4.5. Small for Gestational Age
9.4.6. SHOX Deficiency
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Solvent
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Synthetic Human Growth Hormone Demand Share Forecast, 2019-2026
10. Latin America Synthetic Human Growth Hormone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Synthetic Human Growth Hormone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
10.4.1. Growth Hormone Deficiency (GHD)
10.4.2. Turner Syndrome
10.4.3. Chronic Renal Insufficiency
10.4.4. Prader Willi Syndrome
10.4.5. Small for Gestational Age
10.4.6. SHOX Deficiency
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Solvent
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Synthetic Human Growth Hormone Demand Share Forecast, 2019-2026
11. Europe Synthetic Human Growth Hormone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Synthetic Human Growth Hormone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
11.4.1. Growth Hormone Deficiency (GHD)
11.4.2. Turner Syndrome
11.4.3. Chronic Renal Insufficiency
11.4.4. Prader Willi Syndrome
11.4.5. Small for Gestational Age
11.4.6. SHOX Deficiency
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Solvent
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Synthetic Human Growth Hormone Demand Share, 2019-2026
12. Asia Pacific Synthetic Human Growth Hormone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Synthetic Human Growth Hormone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
12.4.1. Growth Hormone Deficiency (GHD)
12.4.2. Turner Syndrome
12.4.3. Chronic Renal Insufficiency
12.4.4. Prader Willi Syndrome
12.4.5. Small for Gestational Age
12.4.6. SHOX Deficiency
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Solvent
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Synthetic Human Growth Hormone Demand Share, 2019-2026
13. Middle East & Africa Synthetic Human Growth Hormone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Synthetic Human Growth Hormone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Synthetic Human Growth Hormone Market Size and Volume Forecast by Application
13.4.1. Growth Hormone Deficiency (GHD)
13.4.2. Turner Syndrome
13.4.3. Chronic Renal Insufficiency
13.4.4. Prader Willi Syndrome
13.4.5. Small for Gestational Age
13.4.6. SHOX Deficiency
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Synthetic Human Growth Hormone Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Solvent
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Synthetic Human Growth Hormone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Synthetic Human Growth Hormone Market: Market Share Analysis
14.2. Synthetic Human Growth Hormone Distributors and Customers
14.3. Synthetic Human Growth Hormone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novo Nordisk
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck Serono
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. F.Hoffmann-La Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ferring Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GeneScience Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ipsen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LG Life Sciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sandoz International
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Anhui Anke Biotechnology
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BioPartners
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook